Dallas, Texas, Aug. 19, 2020 (Globe NEWSWIRE) — through NEWMEDIAWIRE — NaturalShrimp, Inc., (OTCQB:SHMP), an aquaculture Company which has produced and patented the initial commercially operational Recirculating Aquaculture Process (RAS) for shrimp, announced today that it has filed its preliminary listing software with the NASDAQ, an crucial initially action in the Company’s strategy to uplist its popular inventory on the NASDAQ Capital Market.
“The Enterprise has been working tirelessly to full all of the necessary techniques to successfully fulfill the specifications for listing on the NASDAQ,” explained William Delgado, CFO of NaturalShrimp. “If authorised, on meeting all the listing standards, we really feel this move will supply the Firm the good exposure to support broaden our shareholder base and enhance appeal to institutional investors, ETFs and indexes. By way of our opportunity order of Vero Blue and F&T, we think our small business model style and design presents us a route toward profitability,” extra Mr. Delgado.
Gerald Easterling, CEO of NaturalShrimp, commented, “We imagine NaturalShrimp is at an inflection stage where the Business can develop exponentially. NaturalShrimp has been a pioneer and innovator in the aquaculture marketplace for two many years, and uplisting to the NASDAQ would assist validate our ongoing travel to turn into a leader within the aqua-tech room,” continued Mr. Easterling.
NASDAQ need to approve NaturalShrimp’s software ahead of the Company’s popular inventory can be listed. Although there are no assures that the Company will be permitted, NaturalShrimp is continuing to make strides in conference the listing conditions in the in close proximity to future.
ABOUT NATURALSHRIMP: NaturalShrimp, Inc. is a publicly traded aqua-tech Business, headquartered in Dallas, with output services found close to San Antonio, Texas. The Corporation has produced the to start with commercially feasible method for escalating shrimp in enclosed, salt-h2o techniques, making use of patented technological innovation to make contemporary, never frozen, in a natural way developed shrimp, with no the use of antibiotics or harmful chemicals. NaturalShrimp units can be situated any place in the globe to deliver gourmand-grade Pacific white shrimp.
Ahead Wanting Statements
This press release is made up of “forward-wanting statements.” The statements contained in this push release that are not purely historical are forward-searching statements. Forward-seeking statements give the Firm’s recent expectations or forecasts of potential occasions. This sort of statements are topic to dangers and uncertainties that are usually difficult to forecast and outside of the Company’s regulate, and could bring about the Firm’s success to differ materially from people explained. In some instances ahead-hunting statements can be discovered by terminology this kind of as “might,” “need to,” “probable,” “proceed,” “expects,” “anticipates,” “intends,” “options,” “believes,” “estimates,” and comparable expressions. These statements contain statements relating to going forward with executing the Firm’s world wide advancement method. The statements are based upon present-day beliefs, anticipations and assumptions and are subject to a selection of risks and uncertainties, a lot of of which are tricky to predict. The Organization is offering this information and facts as of the date of this press release and does not undertake any obligation to update any ahead wanting statements contained in this press launch as a end result of new details, long term activities or otherwise, besides as demanded by law. We have centered these forward-searching statements mainly on our current expectations and projections about future functions and economical developments impacting the economical problem of our enterprise. Forward-hunting statements should really not be read as a assure of potential performance or effects, and will not always be correct indications of the instances at, or by, which such performance or effects will be realized. Crucial factors that could cause this kind of differences involve, but are not confined to the Threat Things and other details established forth in the Firm’s Yearly Report on Type 10-Q submitted on November 21, 2019, and in our other filings with the U.S. Securities and Exchange Fee.